Phil Ferneau's most recent trade in Compass Therapeutics Inc was a trade of 40,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Compass Therapeutics Inc | Philip J. Ferneau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Ferneau Phil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Phil Ferneau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Phil Ferneau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) |